Pilot of Mindfulness Oriented Recovery Enhancement in MethadoneTreatment
CompletedNot applicableNCT03894501
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This pilot study aims to evaluate the impact of a novel intervention, Mindfulness Oriented Recovery Enhancement (MORE), on opioid use and chronic pain among individuals receiving methadone maintenance treatment (MMT). The main goal of this pilot study is to test the feasibility of our study methods before conducting a clinical trial to assess MORE with respect to a range of clinical outcomes. This study will involve a 2-arm individually randomized controlled trial design that compares MORE and treatment as usual (TAU).
Study details
- Official title
- Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment for Opioid Use and Chronic Pain Management Pilot
- Conditions
- Interventions
- Behavioral: Mindfulness Oriented Recovery Enhancement
- Behavioral: Methadone program behavioral treatment as usual
- Sponsor
- Rutgers, The State University of New Jersey
- Collaborators
- University of Utah
- Start date
- 2019-01-31
- Primary completion
- 2019-06-19
- Sex
- All
- Age range
- from 18 Years
- Results posted
- Yes, on ClinicalTrials.gov
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Age 18 or older * English-speaking * Been in methadone treatment for at least 3 months * Experience a non-malignant pain (with an intensity level of 8 or higher on the Gracely Box Scale) for a duration of 2 months or longer. Exclusion Criteria: * Exhibit cognitive impairment (score \<24 on the Mini Mental Status Exam) * Exhibit psychosis (positive SCID Psychotic Screen), * Are at suicidal risk (positive score on ASQ Suicide Risk Screening Tool) * Unable to attend group sessions due to distance, work, commitments or other logistical problems, * Are currently pregnant or breastfeeding * Are planning to be pregnant or breastfeeding the next 16 weeks.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03894501